This page includes the latest FDA filings for Boehringer Ingelheim Pharma G M B H Co Kg Bip An Affiliate To Bi Rcv Germany. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2024-11-15 |
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2020-12-30 |
| Swedish Orphan Biovitrum AB (publ), Boehringer Ingelheim Pharma GmbH & Co KG (BIP, an affiliate to BI RCV), Germany, Boehringer Ingelheim RCV, Austria, Charles River Laboratories Edinburgh Ltd., UK, Charles River Laboratories Inc. USA, Eurofins Biolab S.r.l., I | Prescription Medication | 2018-08-07 |